Artificial Intelligence-Guided Tissue Analysis Combined With Immune Infiltrate Assessment Predicts Stage III Colon Cancer Outcomes in PETACC08 Study

Gut - United Kingdom
doi 10.1136/gutjnl-2019-319292
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

The Preoperative Lymphocyte to Monocyte Ratio Predicts Clinical Outcome in Patients With Stage III Colon Cancer

British Journal of Cancer
Cancer ResearchOncology
2013English

Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study

Journal of Surgical Research
Surgery
2020English

Circulating Tumor DNA Analysis Detects Minimal Residual Disease and Predicts Recurrence in Patients With Stage II Colon Cancer

Science Translational Medicine
Medicine
2016English

Management of Stage III Colon Cancer in the Elderly: Practice Patterns and Outcomes in the General Population

Cancer
Cancer ResearchOncology
2017English

Factors Associated With Delayed Time to Adjuvant Chemotherapy in Stage Iii Colon Cancer

Current Oncology
Oncology
2014English

Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer

Scientific Reports
Multidisciplinary
2016English

Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine

Clinical Colorectal Cancer
OncologyGastroenterology
2017English

Identification of Risk Factors Associated With Stage III Disease in Non-Metastatic Colon Cancer: Results From a Prospective National Cohort Study

Annals of Coloproctology
Gastroenterology
2020English

Better Survival in Right-Sided Versus Left-Sided Stage I - III Colon Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy